Gastrointestinal Cancer
ECOG-ACRIN / EA2192
Official Title: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Study Purpose: To see if treating with olaparib compared to the usual approach which is observation, is more successful in preventing pancreatic cancer from coming back
Status:
Recruiting